Literature DB >> 20682224

Management of the adolescent with substance use disorders and comorbid psychopathology.

Oscar G Bukstein1, Michelle S Horner.   

Abstract

Substance use disorders are common in youth, and co-occurring psychiatric disorders are present in the majority of cases. This article reviews clinical considerations unique to the population, including intricacies of assessment and special treatment considerations. Several psychotherapeutic intervention models are discussed, including cognitive-behavioral therapy, dialectic behavior therapy, motivational enhancement therapy/motivational interviewing, family behavior therapy, multidimensional family therapy, and multisystemic therapy. Research on psychopharmacologic treatment is limited, and primarily focuses on mood disorders and attention deficit/hyperactivity disorder. To maximize outcome, recommendations based on practice parameters promote integration of treatment modalities versus serial or concurrent treatment of co-occurring substance use and psychiatric disorders. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20682224     DOI: 10.1016/j.chc.2010.03.011

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  11 in total

1.  Pharmacotherapy for Substance Use Disorders in Youths.

Authors:  Christopher J Hammond; Kevin M Gray
Journal:  J Child Adolesc Subst Abuse       Date:  2016-04-20

2.  Major depression and treatment response in adolescents with ADHD and substance use disorder.

Authors:  Diane Warden; Paula D Riggs; Sung-Joon Min; Susan K Mikulich-Gilbertson; Leanne Tamm; Kathlene Trello-Rishel; Theresa Winhusen
Journal:  Drug Alcohol Depend       Date:  2011-08-31       Impact factor: 4.492

Review 3.  Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model.

Authors:  Leslie A Hulvershorn; Patrick D Quinn; Eric L Scott
Journal:  Curr Drug Abuse Rev       Date:  2015

Review 4.  Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?

Authors:  Stanley Brewer; Mark D Godley; Leslie A Hulvershorn
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 5.  Effects of Brief Interventions on Internalizing Symptoms and Substance Use in Youth: A Systematic Review.

Authors:  Ijeoma Opara; Jessica L Schleider; Riley McDanal; Deanna Parisi
Journal:  Clin Child Fam Psychol Rev       Date:  2021-11-03

Review 6.  Biological contributions to addictions in adolescents and adults: prevention, treatment, and policy implications.

Authors:  Marc N Potenza
Journal:  J Adolesc Health       Date:  2013-02       Impact factor: 5.012

7.  Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol.

Authors:  Xavier Benarous; Yves Edel; Angèle Consoli; Julie Brunelle; Jean-François Etter; David Cohen; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2016-09-20       Impact factor: 4.157

8.  Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis.

Authors:  Valerie Giang; Madison Thulien; Ryan McNeil; Kali Sedgemore; Haleigh Anderson; Danya Fast
Journal:  SSM Popul Health       Date:  2020-06-04

9.  A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan.

Authors:  Liang-Jen Wang; Shing-Fang Lu; Wen-Jiun Chou; Mian-Yoon Chong; Yao-Hsing Wang; Yu-Lian Hsieh; Yi-Hsuan Lee; Ching Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-31       Impact factor: 2.570

10.  A family-oriented therapy program for youths with substance abuse: long-term outcomes related to relapse and academic or social status.

Authors:  Liang-Jen Wang; Shing-Fang Lu; Mian-Yoon Chong; Wen-Jiun Chou; Yu-Lian Hsieh; Tung-Ning Tsai; Ching Chen; Yi-Hsuan Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-30       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.